How to improve R&D productivity: the pharmaceutical industry's grand challenge
SM Paul, DS Mytelka, CT Dunwiddie… - Nature reviews Drug …, 2010 - nature.com
The pharmaceutical industry is under growing pressure from a range of environmental
issues, including major losses of revenue owing to patent expirations, increasingly cost …
issues, including major losses of revenue owing to patent expirations, increasingly cost …
Chemometrics in metabolomics—a review in human disease diagnosis
R Madsen, T Lundstedt, J Trygg - Analytica chimica acta, 2010 - Elsevier
Metabolomics is a post genomic research field concerned with developing methods for
analysis of low molecular weight compounds in biological systems, such as cells, organs or …
analysis of low molecular weight compounds in biological systems, such as cells, organs or …
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
Because of its availability, ease of collection, and correlation with physiology and pathology,
urine is an attractive source for clinical proteomics/peptidomics. However, the lack of …
urine is an attractive source for clinical proteomics/peptidomics. However, the lack of …
Subgroup identification based on differential effect search—a recursive partitioning method for establishing response to treatment in patient subpopulations
I Lipkovich, A Dmitrienko, J Denne… - Statistics in …, 2011 - Wiley Online Library
We propose a novel recursive partitioning method for identifying subgroups of subjects with
enhanced treatment effects based on a differential effect search algorithm. The idea is to …
enhanced treatment effects based on a differential effect search algorithm. The idea is to …
Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type
Simple Summary The progress of next-generation sequencing technologies has raised
huge expectations for precision-medicine therapy approaches in breast cancer and triple …
huge expectations for precision-medicine therapy approaches in breast cancer and triple …
[HTML][HTML] The faces of personalized medicine: a framework for understanding its meaning and scope
WK Redekop, D Mladsi - Value in Health, 2013 - Elsevier
The objective of this article was to provide a framework for understanding the different
definitions of the term “personalized medicine.” The term personalized medicine is used …
definitions of the term “personalized medicine.” The term personalized medicine is used …
The FDA critical path initiative and its influence on new drug development
J Woodcock, R Woosley - Annu. Rev. Med., 2008 - annualreviews.org
Societal expectations about drug safety and efficacy are rising while productivity in the
pharmaceutical industry is falling. In 2004, the US Food and Drug Administration introduced …
pharmaceutical industry is falling. In 2004, the US Food and Drug Administration introduced …
Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use
FW Frueh, S Amur, P Mummaneni… - … : The Journal of …, 2008 - Wiley Online Library
Study Objectives. To review the labels of United States Food and Drug Administration (FDA)‐
approved drugs to identify those that contain pharmacogenomic biomarker information, and …
approved drugs to identify those that contain pharmacogenomic biomarker information, and …
Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data
JP Laurenson, RA Bloom, S Page, N Sadrieh - The AAPS journal, 2014 - Springer
Interest in pharmaceuticals in the environment has increased substantially in recent years.
Several studies in particular have assessed human and ecological risks from human …
Several studies in particular have assessed human and ecological risks from human …
Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert Forum
I Raz, MC Riddle, J Rosenstock, JB Buse, SE Inzucchi… - 2013 - Am Diabetes Assoc
In June 2012, 13 thought leaders convened in a Diabetes Care Editors' Expert Forum to
discuss the concept of personalized medicine in the wake of a recently published American …
discuss the concept of personalized medicine in the wake of a recently published American …